Evogene Ltd

-0.11 (-4.10%)
: $2.70 +0.13 (+5.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)104.40M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.12 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$2.60
50-Day MA$2.79
200-Day MA$4.20
See more pivots

Evogene Ltd Stock, NASDAQ:EVGN

13 Gad Feinstein Street, Park Rehovot, Rehovot, HaMerkaz 76121
Phone: +972.8.931.1900
Number of Employees: 131


Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agrobiological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.